High-Throughput Mass Spectrometry Analytics for ML/AI-Ready Drug Discovery

August 5, 2025

As the demand for scalable mass spectrometry (MS) analytics increases, standardized data acquisition and automation of time-consuming manual processes are needed to deliver high-throughput, quality results. By streamlining information exchange with centralized data management systems, data processing from different vendors, and result review, the Genedata Biopharma Platform enables large-scale screening and generation of structured datasets for machine learning (ML) and artificial intelligence (AI)-ready drug discovery, supporting enterprise-level biopharma digitalization and delivering faster insights for decision-making.